SAB Biotherapeutics Stock (NASDAQ: SABSW)

SAB Biotherapeutics (NASDAQ:SABSW) Stock, Quote.Headers.trade-ideas

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

SAB Biotherapeutics Inc

WIIM

LAES

QBTS

QUBT

RGTI

Shares of quantum computing companies are trading higher. The sector has recently seen increased interest.

Financial giants have made a conspicuous bearish move on Fair Isaac. Our analysis of options history for Fair Isaac (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FICO#NYSE">FICO</a>) revealed 9 unusual trades.
Delving into the details, we found 33% of traders were bullish, while 44% showed bearish tendencies. Out of all the trades we spotted, 5 were puts, with a value of $380,460, and 4 were calls, valued at $170,160.
<h3>Predicted Price Range</h3>
Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $1340.0 to $3000.0 for Fair Isaac during the past quarter. 
<h3>Analyzing Volume &amp; Open Interest</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Fair Isaac's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Fair Isaac's whale activity within a strike price range from $1340.0 to $3000.0 in the last 30 days. 
<h3>Fair Isaac Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1735838136_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>FICO</td>
<td>PUT</td>
<td>TRADE</td>
<td>NEUTRAL</td>
<td>12/19/25</td>
<td>$446.8</td>
<td>$428.0</td>
<td>$436.0</td>
<td>$2380.00</td>
<td>$130.8K</td>
<td align="right">3</td>
<td align="right">3</td>
</tr>
<tr>
<td>FICO</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>12/19/25</td>
<td>$1000.0</td>
<td>$992.0</td>
<td>$1000.0</td>
<td>$3000.00</td>
<td>$100.0K</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>FICO</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>12/19/25</td>
<td>$255.9</td>
<td>$245.5</td>
<td>$245.5</td>
<td>$2080.00</td>
<td>$73.6K</td>
<td align="right">3</td>
<td align="right">0</td>
</tr>
<tr>
<td>FICO</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/17/25</td>
<td>$667.0</td>
<td>$658.0</td>
<td>$658.0</td>
<td>$1340.00</td>
<td>$65.8K</td>
<td align="right">6</td>
<td align="right">0</td>
</tr>
<tr>
<td>FICO</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>03/21/25</td>
<td>$460.0</td>
<td>$450.0</td>
<td>$460.0</td>
<td>$2460.00</td>
<td>$46.0K</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>

<h3>About Fair Isaac</h3>
Founded in 1956, Fair Isaac Corporation is a leading applied analytics company. Fair Isaac is primarily known for its FICO credit scores, which is a widely used industry benchmark to determine the creditworthiness of an individual consumer. The firm's credit scores business accounts for most of the firm's profits and consists of business-to-business and business-to-consumer services. In addition to scores, Fair Isaac also sells software primarily to financial institutions for areas such as analytics, decision-making, customer workflows, and fraud.
Following our analysis of the options activities associated with Fair Isaac, we pivot to a closer look at the company's own performance.
<h3>Where Is Fair Isaac Standing Right Now?</h3>
<ul>
<li>With a trading volume of 63,882, the price of FICO is up by 0.75%, reaching $2005.89.</li>
<li>Current RSI values indicate that the stock is may be oversold.</li>
<li>Next earnings report is scheduled for 21 days from now.</li>
</ul>
<h3>Professional Analyst Ratings for Fair Isaac</h3>
A total of 2 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $2405.5.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; An analyst from Goldman Sachs has decided to maintain their Buy rating on Fair Isaac, which currently sits at a price target of $2661. 
&#x2A; Reflecting concerns, an analyst from JP Morgan lowers its rating to Neutral with a new price target of $2150.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Fair Isaac, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

Options

Markets

FICO

Fair Isaac Unusual Options Activity

Whales with a lot of money to spend have taken a noticeably bearish stance on Root.
Looking at options history for Root (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ROOT#NASDAQ">ROOT</a>) we detected 9 trades.
If we consider the specifics of each trade, it is accurate to state that 0% of the investors opened trades with bullish expectations and 77% with bearish.
From the overall spotted trades, 6 are puts, for a total amount of $244,616 and 3, calls, for a total amount of $90,513.
<h3>Projected Price Targets</h3>
Based on the trading activity, it appears that the significant investors are aiming for a price territory stretching from $55.0 to $100.0 for Root over the recent three months. 
<h3>Volume &amp; Open Interest Development</h3>
Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.
This data can help you track the liquidity and interest for Root's options for a given strike price.
Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Root's whale activity within a strike price range from $55.0 to $100.0 in the last 30 days. 
<h3>Root 30-Day Option Volume &amp; Interest Snapshot</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1735838130_0.png" alt="Options Call Chart" />
<h3>Noteworthy Options Activity:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>ROOT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$8.6</td>
<td>$8.4</td>
<td>$8.4</td>
<td>$70.00</td>
<td>$66.3K</td>
<td align="right">1</td>
<td align="right">247</td>
</tr>
<tr>
<td>ROOT</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$38.0</td>
<td>$37.8</td>
<td>$37.8</td>
<td>$100.00</td>
<td>$41.5K</td>
<td align="right">6</td>
<td align="right">20</td>
</tr>
<tr>
<td>ROOT</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$8.6</td>
<td>$7.1</td>
<td>$8.2</td>
<td>$70.00</td>
<td>$40.9K</td>
<td align="right">1</td>
<td align="right">52</td>
</tr>
<tr>
<td>ROOT</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>02/21/25</td>
<td>$8.8</td>
<td>$7.7</td>
<td>$8.4</td>
<td>$70.00</td>
<td>$37.8K</td>
<td align="right">1</td>
<td align="right">97</td>
</tr>
<tr>
<td>ROOT</td>
<td>CALL</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>06/20/25</td>
<td>$28.3</td>
<td>$26.6</td>
<td>$28.3</td>
<td>$55.00</td>
<td>$33.9K</td>
<td align="right">42</td>
<td align="right">14</td>
</tr>
</tbody>
</table>

<h3>About Root</h3>
Root Inc develops and launches a direct-to-consumer personal automobile insurance and mobile technology company. The company is a direct-to-consumer personal auto insurance, renters insurance and mobile technology company. It generates revenue from the sale of auto insurance policies within the United States.
Having examined the options trading patterns of Root, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance
<h3>Root's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 110,637, the ROOT's price is up by 3.37%, now at $75.04. </li>
<li>RSI readings suggest the stock is currently may be oversold.</li>
<li>Anticipated earnings release is in 48 days.</li>
</ul>
Unusual Options Activity Detected: Smart Money on the Move
Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=Be8be9arja3be22bz20&amp;utm_source=benzinga-insights">Click here for access</a>.
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Root, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

ROOT

Looking At Root's Recent Unusual Options Activity

Financial giants have made a conspicuous bearish move on Regeneron Pharmaceuticals. Our analysis of options history for Regeneron Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/REGN#NASDAQ">REGN</a>) revealed 10 unusual trades.
Delving into the details, we found 30% of traders were bullish, while 50% showed bearish tendencies. Out of all the trades we spotted, 7 were puts, with a value of $518,443, and 3 were calls, valued at $365,370.
<h3>Predicted Price Range</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $700.0 and $1000.0 for Regeneron Pharmaceuticals, spanning the last three months.
<h3>Volume &amp; Open Interest Development</h3>
In terms of liquidity and interest, the mean open interest for Regeneron Pharmaceuticals options trades today is 85.5 with a total volume of 234.00.
In the following chart, we are able to follow the development of volume and open interest of call and put options for Regeneron Pharmaceuticals's big money trades within a strike price range of $700.0 to $1000.0 over the last 30 days.
<h3>Regeneron Pharmaceuticals Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1735838125_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th align="right">Open Interest</th>
<th align="right">Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>REGN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>08/15/25</td>
<td>$73.0</td>
<td>$70.0</td>
<td>$73.0</td>
<td>$720.00</td>
<td>$270.1K</td>
<td align="right">6</td>
<td align="right">37</td>
</tr>
<tr>
<td>REGN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>06/20/25</td>
<td>$37.1</td>
<td>$37.0</td>
<td>$37.1</td>
<td>$820.00</td>
<td>$241.1K</td>
<td align="right">9</td>
<td align="right">65</td>
</tr>
<tr>
<td>REGN</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>12/18/26</td>
<td>$77.0</td>
<td>$73.0</td>
<td>$73.0</td>
<td>$1000.00</td>
<td>$73.0K</td>
<td align="right">78</td>
<td align="right">10</td>
</tr>
<tr>
<td>REGN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>01/17/25</td>
<td>$19.9</td>
<td>$18.4</td>
<td>$19.9</td>
<td>$715.00</td>
<td>$59.7K</td>
<td align="right">9</td>
<td align="right">57</td>
</tr>
<tr>
<td>REGN</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$22.5</td>
<td>$18.4</td>
<td>$20.0</td>
<td>$715.00</td>
<td>$54.0K</td>
<td align="right">9</td>
<td align="right">27</td>
</tr>
</tbody>
</table>

<h3>About Regeneron Pharmaceuticals</h3>
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including low-dose Eylea and Eylea HD, approved for wet age-related macular degeneration and other eye diseases; Dupixent in immunology; Praluent for LDL cholesterol lowering; Libtayo in oncology; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal and bispecific antibodies with Sanofi, other collaborators, and independently, and has earlier-stage partnerships that bring new technology to the pipeline, including RNAi (Alnylam) and Crispr-based gene editing (Intellia).
Following our analysis of the options activities associated with Regeneron Pharmaceuticals, we pivot to a closer look at the company's own performance.
<h3>Regeneron Pharmaceuticals's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 102,419, the REGN's price is up by 0.45%, now at $715.52. </li>
<li>RSI readings suggest the stock is currently may be approaching oversold.</li>
<li>Anticipated earnings release is in 29 days.</li>
</ul>
<h3>What The Experts Say On Regeneron Pharmaceuticals</h3>
2 market experts have recently issued ratings for this stock, with a consensus target price of $365.0.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;utm_source=benzinga-insights">Click here for access</a>. 
&#x2A; In a cautious move, an analyst from Canaccord Genuity downgraded its rating to Hold, setting a price target of $165. 
&#x2A; An analyst from B of A Securities downgraded its action to Underperform with a price target of $565. 
Options are a riskier asset compared to just trading the stock, but they have higher profit potential. Serious options traders manage this risk by educating themselves daily, scaling in and out of trades, following more than one indicator, and following the markets closely.
If you want to stay updated on the latest options trades for Regeneron Pharmaceuticals, <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> gives you real-time options trades alerts.

REGN

Regeneron Pharmaceuticals Unusual Options Activity

Goldman Sachs analyst Eric Sheridan maintains Uber Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UBER#NYSE">UBER</a>) with a Buy and maintains $96 price target.

News

Price Target

Analyst Ratings

UBER

Goldman Sachs Maintains Buy on Uber Technologies, Maintains $96 Price Target

Thousands of port workers may go on strike again as a temporary deal between the International Longshoremen's Association and United States Maritime Alliance reached in October is <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41187855/port-strike-ends-after-3-days-retaliers-politicians-breathe-a-sigh-of-relief">set to expire on Jan. 15.&nbsp;</a>
The Details: The current agreement was reached after a three-day port strike in October affected ports on the Gulf and East Coasts. The dockworkers had sought a 77% pay increase over the next six years and workplace protections for automation of port practices.&nbsp;
The tentative deal that was reached increased pay by 62%, but did not address the union's concerns about automation.&nbsp;
Read Next: <a href="https://www.benzinga.com/news/global/24/12/42743937/natural-gas-prices-spike-as-bone-chilling-arctic-blast-approaches">Natural Gas Prices Spike As &#8216;Bone-Chilling&#8217; Arctic Blast Approaches</a>
A <a href="https://www.usmx.com/assets/content/public-resources/12-20-2024_Statement_from_USMX.pdf">message</a> from the United States Marine Alliance dated Dec. 20 addressed the use of technology and automation in ports.&nbsp;
"​​Evolving port operations and increasing wages and jobs for the ILA are not mutually exclusive. Modern technology is proven to dramatically increase the amount of cargo that can be moved through a port annually. ILA members make more money when they move more cargo and ports need to hire more workers to manage that growth," the message stated.&nbsp;
Harold Daggett, president of the International Longshoreman's Association, hinted at a potential strike in a Christmas Day <a href="https://ilaunion.org/harold-j-daggett-international-president-international-longshoremens-association-2024-christmas-message-to-ila-members-and-their-families/">message to</a> union members.&nbsp;
"Our resolve may be tested again in mid-January as we face another deadline for negotiating a new Master Contract by January 15, 2025. We want to avoid another strike, and hope that our employers represented by United States Maritime Alliance will respect our demands for a fair and decent contract," Daggett wrote.&nbsp;
Why It Matters: Container shipping company ZIM Integrated Shipping Services Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ZIM#NYSE">ZIM</a>) <a href="https://www.zim.com/customer-updates/new-ila-strike-surcharge-for-cargo-moving-to-or-from-the-us-east-coastus-gulf-ports">announced an</a> ILA Strike Surcharge in mid-December for all cargo moving to or from US East Coast and US Gulf ports effective from Jan. 10 in the event of a strike. 
Zim said the charge is intended to help mitigate "additional costs and expenses to ZIM caused by a strike, work stoppage, work slowdown or other labor-related disruptions to operations" and will not apply if a strike is averted.&nbsp;
Ground shipping and freight companies like FedEx Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FDX#NYSE">FDX</a>) and United Parcel Service, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>) could benefit in the event of a port strike as businesses would shift toward ground and air transportation of goods.&nbsp;
Investors can also monitor the effects of a potential port strike through the SonicShares Global Shipping ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOAT#NYSE">BOAT</a>) which tracks the Solactive Global Shipping Index consisting of global shipping companies engaged in maritime transportation of goods and raw materials.&nbsp;
Read More:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/25/01/42768507/china-slaps-export-restrictions-on-dozens-of-us-companies-boeing-lockheed-martin-general-dynamics-raytheon-affected">China&#8217;s Export Crackdown Hits Boeing, Lockheed Martin And More&nbsp;</a></li>
</ul>
Image: Shutterstock

Movers

BOAT

Another Potential East Coast Port Strike Is Brewing: 4 Stocks To Watch

MRVL

NVDA

Shares of chip stocks are trading higher amid continued momentum from 2024.

Wells Fargo analyst Michael Turrin maintains Twilio (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TWLO#NYSE">TWLO</a>) with a Overweight and raises the price target from $120 to $140.

TWLO

Wells Fargo Maintains Overweight on Twilio, Raises Price Target to $140

On Thursday, H. B. Fuller Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FUL#NYSE">FUL</a>) disclosed its unaudited preliminary financial results for fiscal year 2024, highlighting weaker-than-expected <a target="_blank" href="https://www.benzinga.com/pressreleases/25/01/b42763305/h-b-fuller-announces-preliminary-fiscal-year-2024-results" rel="noreferrer noopener">conditions in the fourth quarter.</a>
The company now projects fiscal year 2024 net revenue to reach approximately $3.57 billion versus $3.576 billion estimate (prior view: ~$3.581 billion), with adjusted earnings per share of $3.84 versus the analyst consensus estimate of $4.16 (<a target="_blank" href="https://www.benzinga.com//node/41034261" rel="noreferrer noopener">prior view: $4.10 to $4.20</a>).
The company currently expects Adjusted EBITDA of approximately $594 million, representing a revision from previous guidance, which had forecasted adjusted EBITDA in the range of $610 million to $620 million.
The fourth-quarter performance was negatively impacted by delayed customer orders and weaker-than-expected demand in key sectors, including consumer product goods, packaging, and durable goods distribution.
Also Read: <a target="_blank" href="https://www.benzinga.com/trading-ideas/movers/25/01/42766117/tesla-stock-tumbles-on-q4-deliveries-whats-going-on" rel="noreferrer noopener">Tesla Stock Tumbles On Q4 Deliveries: What&#8217;s Going On?</a>
Additionally, the shift in price increase realization into fiscal 2025 and rising raw material costs, particularly in Hygiene, Health, and Consumable Adhesives, contributed to the decline in adjusted EBITDA.
Celeste Mastin, President and CEO, acknowledged the market slowdown and emphasized the company's response, including new pricing actions, cost controls, and ongoing restructuring initiatives to streamline manufacturing and reduce operating costs.
H. B. Fuller also expects operating cash flow to be approximately $300 million for fiscal 2024, down from the prior outlook of $325 million&nbsp;&#8211; $350 million.
The company will release its full financial results on January 15, 2025, followed by an investor conference call on <a target="_blank" href="https://www.benzinga.com/earnings" rel="noreferrer noopener">January 16, 2025, to discuss the results.</a>
Price Action: FUL shares are trading lower by 6.14% to $63.34 at last check Thursday.
Check This Out:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/equities/25/01/42762223/tesla-shares-rise-in-thursday-premarket-despite-recent-cybertruck-explosion-outside-trumps-las-vegas-hotel-heres-why" target="_blank" rel="noreferrer noopener">Tesla Shares Rise In Thursday Premarket After Cybertruck Qualifies For $7,500 EV Tax Credit</a></li>
</ul>

Equities

General

H.B. Fuller Adjusts FY24 Outlook: Delayed Orders And Rising Costs Weigh On Results

Bank of America Corp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BAC#NYSE">BAC</a>) and Citigroup Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/C#NYSE">C</a>) became today the latest banks to end association with the <a href="https://www.benzinga.com/topic/clean-energy" target="_blank" rel="noreferrer noopener">climate alliance</a> for banks.
Goldman Sachs Group, Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>) and Wells Fargo &amp; Co (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WFC#NYSE">WFC</a>) already exited from Net-Zero Banking Alliance, the Financial Times <a href="https://www.ft.com/content/acaeff4c-175c-41a0-806b-e870f1f1f53d" target="_blank" rel="noreferrer noopener">reports</a>.
The initiative focused on containing global warming by limiting investment in industries contributing to greenhouse gas emissions.
Citi told the Financial Times it remained committed to its climate goals and planned to channel its efforts toward emerging markets.
BofA told the Financial Times it would collaborate with clients to accomplish climate targets.
Republican lawmakers urged U.S. banks and other large companies to avoid pledges that would prompt them to lend less to the oil and gas industry or other traditional energy producers. That pressure intensified after Donald Trump&#8217;s presidential win.
The Trump administration <a href="https://www.benzinga.com/markets/commodities/24/11/42235640/trumps-energy-policies-poised-to-reshape-oil-gas-market-winners-and-losers-revealed" target="_blank" rel="noreferrer noopener">plans to increase</a> energy production by three million barrels of oil equivalent per day, impose a potential 25% tariff on Canadian oil and gas imports, and fast-track approvals for liquefied natural gas (LNG) exports.
Analysts remain divided over the impact of Trump&#8217;s victory on the clean energy sector.
JPMorgan&#8217;s&nbsp;Anthony Elian <a href="https://www.benzinga.com/etfs/sector-etfs/24/11/41788181/regional-bank-stocks-notch-strongest-day-in-4-years-why-analysts-expect-several-tailwinds-from-t" target="_blank" rel="noreferrer noopener">expects Trump&#8217;s policies</a> to boost regional banks by encouraging lending, easing regulations and lowering corporate taxes.
Investors anticipate benefits for smaller, U.S.-focused institutions, driving surges in regional bank stocks and broader small-cap markets.
Carl Fleming of McDermott Will &amp; Emery <a href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/41772327/trumps-return-to-white-wont-have-shocking-effect-on-us-clean-energy-growth-say-anal" target="_blank" rel="noreferrer noopener">predicts a</a> Trump administration could slow clean energy growth by cutting federal budgets and restricting offshore wind leases.
Fleming believes these actions would have a limited impact on the broader renewables market, which relies less on federal funding.
Morgan Stanley <a target="_blank" href="https://www.benzinga.com/analyst-ratings/analyst-color/24/11/42016909/trumps-win-economic-challenges-lead-to-tougher-outlook-for-renewable-energy-stocks-morgan-stanley" rel="noreferrer noopener">downgraded clean tech stocks</a>, including SolarEdge Technologies, Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SEDG#NASDAQ">SEDG</a>), citing competition, tariff concerns, and uncertainty about the Inflation Reduction Act (IRA).
BAC, C Price Actions: At publication Thursday, Bank of America stock is up 0.78% at $44.33, Citibank is up 0.28% at $70.60.
Read Next: <a href="https://www.benzinga.com/trading-ideas/movers/25/01/42766117/tesla-stock-tumbles-on-q4-deliveries-whats-going-on"> • Tesla Stock Tumbles On Q4 Deliveries: What&#8217;s Going On?</a>
This image was created using artificial intelligence.

Government

Regulations

Global

Media

SEDG

Bank of America, Citigroup Exit Climate Alliance As Trump Policies Shift Energy Priorities

Wells Fargo analyst Whit Mayo maintains Bank of New York Mellon (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BK#NYSE">BK</a>) with a Equal-Weight and raises the price target from $81 to $82.

Wells Fargo Maintains Equal-Weight on Bank of New York Mellon, Raises Price Target to $82

<a href="https://www.courtlistener.com/docket/68858516/174/mcp-no-185-open-internet-rule-fcc-24-52/" title="https://www.courtlistener.com/docket/68858516/174/mcp-no-185-open-internet-rule-fcc-24-52/">https://www.courtlistener.com/docket/68858516/174/mcp-no-185-open-internet-rule-fcc-24-52/</a>

Legal

TMUS

U.S. Appeals Court Blocks Biden Administration Order Reinstating Net Neutrality Rules

Wells Fargo analyst Mike Mayo maintains State Street (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/STT#NYSE">STT</a>) with a Overweight and raises the price target from $108 to $118.

Wells Fargo Maintains Overweight on State Street, Raises Price Target to $118

Stock traders and golfers almost universally have one trait in common: they are always on the hunt for a pro tip that will help them improve their game or investment portfolios. Former TD Ameritrade CEO Joe Moglia would certainly qualify as a "pro" when it comes to stock trading. During a recent appearance on CNBC's Fast Money, Moglia offered his opinion on strategies to help traders play the market in 2025.
Don't Miss:
<ul>
<li>This Jeff Bezos-backed startup will allow you to <a href="https://arrivedhomes.go2cloud.org/aff_c?offer_id=15&amp;aff_id=1006&amp;aff_sub=yahoo&amp;aff_sub2=byerscta100">become a landlord in just 10 minutes, with minimum investments as low as $100 for properties like the Byer House from Stranger Things.</a></li>
<li>Unlock the hidden potential of commercial real estate —<a href="https://equitymultiple.com/benzinga?invite=benzinga&amp;utm_campaign=product-promotion-earn&amp;utm_source=yahooFinance&amp;utm_medium=affiliate&amp;utm_content=unlockboost-yahoo"> This platform allows individuals to invest in commercial real estate offering a 12% target yield with a bonus 1% return boost today!</a></li>
</ul>
Perhaps the most striking aspect of Moglia's interview was his admission that he's "the most bullish on the market that he's been in 10 years," which should encourage investors. When the hosts asked him why he felt this way, Moglia quickly said, "The president, we've got someone in there who is pro-business, pro-markets." He also noted how President-Elect Trump has warmed up to Cryptocurrency, a change from several years ago.
The host noted that Moglia manages his portfolio and that more than half of it in "growth stuff, including Crypto,<a href="https://www.benzinga.com/24/12/42696614/cathie-wood-takes-profit-on-hot-ai-stock-palantir-again-continues-to-sell-block-shares-amid-bitcoin-buzz"> Cathie Wood</a> kind of stuff, tech stocks" before asking him, "How does that align with the retail trader?" Joe responded, "I think today, if you're an individual trader, I don't know how you expect to have good performance if you're not involved with technology (stocks)."
See Also: ‘Scrolling To UBI' — Deloitte's #1 fastest-growing software company allows users to earn money on their phones. <a href="https://www.benzinga.com/money/mode-mobile-y2">You can invest today for just $0.26/share with a $1000 minimum.</a>
He also suggested several potential starting points for retail traders when he said, "The<a href="https://www.benzinga.com/markets/equities/24/11/41756882/magnificent-7-basket-notches-over-200-gain-since-bidens-election-how-did-tech-giants-perform-und"> Magnificent Seven</a> is a good place to be" and suggested tracking Cathie Wood's trades in this sector. Moglia also detailed how he, much like the President-Elect, has evolved his views on cryptocurrency and is now very much in favor of it being part of retail investor portfolios.
He expanded that by saying, "You've got the crypto play, which I think five years ago or two years ago, that may have been overly aggressive, but I think you have to be involved now." Although Moglia's ideal portfolio holdings have changed from 10 years ago, he remains a proponent of the "barbell method," where the portfolio is equally balanced on each side with risk and growth, with long-term holdings in between for balance.&nbsp;
Trending: Wondering if your investments can get you to a $5,000,000 nest egg? Speak to a financial advisor today.<a href="https://smartasset.com/retirement/find-a-financial-planner?utm_source=benzinga&amp;utm_campaign=ben&amp;utm_content=y2_5MilNestEgg"> SmartAsset&#8217;s free tool matches you up with up to three vetted financial advisors who serve your area, and you can interview your advisor matches at no cost</a> to decide which one is right for you.
Moglia also explained how that barbell may be differently weighted and affected by factors such as the investor's age, goals and risk tolerance. The hosts asked him to compare today's retail investor with the retail investor of 10 years ago. Moglia responded that today's investors have better financial literacy and access to more information than they did 10 years ago. He also believes today's investors are more aggressive.
Moglia made another salient point when he stressed that losing money in a bull market is still possible. Although Moglia believes in the Magnificent Seven and cryptocurrency, he stressed the importance of retail investors planning their investment strategy and staying on top of their portfolios. Moglia quipped, "Lots of families spend more time planning vacations than they do their investment portfolios."&nbsp;
Read Next:
<ul>
<li><a href="https://www.benzinga.com/go/arrived-private-credit-yf">Arrived Home's Private Credit Fund&#8217;s has historically paid an annualized dividend yield of 8.1%&#x2A;</a>, which provides access to a pool of short-term loans backed by residential real estate with just a $100 minimum.<a href="https://www.benzinga.com/go/arrived-private-credit-yf"> </a></li>
<li>Commercial real estate has historically outperformed the stock market, and<a href="https://equitymultiple.com/benzinga?invite=benzinga&amp;utm_campaign=product-promotion-earn&amp;utm_source=yahooFinance&amp;utm_medium=affiliate&amp;utm_content=stockmarket-yahoo"> this platform allows individuals to invest in commercial real estate with as little as $5,000 offering a 12% target yield with a bonus 1% return boost today!</a></li>
</ul>

Real Estate

Former TD Ameritrade CEO Joe Moglia On Which Strategies Traders Can Use To Play The Market In 2025

Meta Platforms shares are trading higher after JMP Securities raised its price target on the stock from $660 to $750.

In the current market session, Beacon Roofing Supply Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BECN#NASDAQ">BECN</a>) share price is at $102.70, after a 1.10% increase. Moreover, over the past month, the stock fell by 10.91%, but in the past year, went up by 16.78%. Shareholders might be interested in knowing whether the stock is overvalued, even if the company is performing up to par in the current session. 

<img src="https://www.benzinga.com/files/images/story/2025/1735837209_0.png" alt="Past Year Chart" />

<h3>Evaluating Beacon Roofing Supply P/E in Comparison to Its Peers</h3>
The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and aggregate market data for the industry or the indices, such as S&amp;P 500. A higher P/E indicates that investors expect the company to perform better in the future, and the stock is probably overvalued, but not necessarily. It also could indicate that investors are willing to pay a higher share price currently, because they expect the company to perform better in the upcoming quarters. This leads investors to also remain optimistic about rising dividends in the future. 
Beacon Roofing Supply has a lower P/E than the aggregate P/E of 93.58 of the Trading Companies &amp; Distributors industry. Ideally, one might believe that the stock might perform worse than its peers, but it's also probable that the stock is undervalued. 

<img src="https://www.benzinga.com/files/images/story/2025/1735837209_1.png" alt="Guage" />

In conclusion, the price-to-earnings ratio is a useful metric for analyzing a company's market performance, but it has its limitations. While a lower P/E can indicate that a company is undervalued, it can also suggest that shareholders do not expect future growth. Additionally, the P/E ratio should not be used in isolation, as other factors such as industry trends and business cycles can also impact a company's stock price. Therefore, investors should use the P/E ratio in conjunction with other financial metrics and qualitative analysis to make informed investment decisions.

Intraday Update

BECN

P/E Ratio Insights for Beacon Roofing Supply

AAPL

Apple shares are trading lower after reports indicating the company is discounting iPhone 16 prices in China.

Constellation shares are trading higher after the company announced it won $1 billion in combined contracts from the U.S. General Services Administration.

UBS analyst Shaleen Kumar upgrades Wipro (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WIT#NYSE">WIT</a>) from Sell to Neutral.

Upgrades

UBS Upgrades Wipro to Neutral

Macro Economic Events

Economics

SPDR Dow Jones Industrial Average ETF Trust

Major indexes are higher, with chip stocks rising to begin 2025.

SAB Biotherapeutics rebrands as SAB BIO; reaffirms full-year outlook

SABS

SABSW

Press Releases

SAB Biotherapeutics to Present at the American Diabetes Association 84th Scientific Sessions

Health Care

SAb Biotherapeutics Rebrands as SAB BIO

Management

SAB BIO Appoints Lucy To as Chief Financial Officer

SAB BIO Announces Founding of Clinical Advisory Board to Guide the Development of SAB-142 for Type 1 Diabetes

Earnings

SAB BIO Announces Second Quarter 2024 Financial Results and Provides Company Updates

SAB BIO to Present at the European Association for the Study of Diabetes 60th Annual Meeting

SAB BIO Provides SAB-142 Clinical Trial Progress Update at the European Association for the Study of Diabetes Annual Meeting

Biotech

SAB BIO CEO to Participate in Fireside Chat at 2024 Cantor Global Healthcare Conference

SAB BIO CEO to Participate in Fireside Chat at Guggenheim Securities Healthcare Innovation Conference

SAB BIO Announces Third Quarter 2024 Financial Results and Provides Company Update

Comments

SAB Biotherapeutics

SAB Biotherapeutics (SABSW) Forecast

SAB Biotherapeutics (NASDAQ:SABSW) Stock, Quote.Headers.trade-ideas

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga